Unmatched quality in pharmaceutical logistics: Why it matters
Ensuring the integrity of pharmaceutical products is one of the most complex challenges in global healthcare today. From temperature-sensitive biologics…
All articles by
-
-
Artificial intelligence is making clinical supply chains more efficient and more sustainable: here’s how
The pharmaceutical industry is in the midst of a digital revolution; technology investments and data-driven decision-making are constantly on the…
-
How CNS researchers are handling clinical trial turbulence
The field of central nervous system (CNS) drug development is awash with activity. Data from GlobalData’s drugs database, as of…
-
Navigating the complexities of sustainable specialty pharma supply chains
The pharmaceutical world is changing. Sales of personalised therapies, for example, will skyrocket from $8 billion in 2022 to a…
-
Revolutionary approaches to drug design: how AI is transforming life sciences
With 2025 well underway, the runaway momentum of artificial intelligence (AI) looks unstoppable. GlobalData estimates that the total AI market…
-
Trying Times for Biopharmaceuticals: How Researchers Can Flourish Amid Industry Challenges
Times are tough in the biopharmaceutical industry. Challenges including regulatory hurdles, supply chain fragility, geopolitical tensions and macroeconomic pressures are…
-
How a Fresh Approach to Supply Chains Can Unlock Scaling in Personalized Medicine
Precision medicine represents a new frontier in healthcare. By stratifying patients based on genomic and phenotypic variations, it addresses the…
-
Oncology R&D: emerging therapies and new challenges
The oncology market, already huge, is set for major expansion. According to analysis from GlobalData, it will generate trillions of…
-
Building up the infrastructure for future pandemic preparedness: Frontiers in rapid raw material production
With the world facing threats from new and emerging infectious diseases, the ability to rapidly ramp up production of essential…
-
Overcoming the first hurdles: Navigating early phase challenges for biotechs
As smaller, leaner organisations that must utilise resources carefully, biotechs face unique challenges as they enter clinical trials. These challenges…
